ClearPoint Neuro, Inc. (CLPT)
13.84
+0.10
(+0.69%)
USD |
NASDAQ |
Jun 11, 16:00
13.84
0.00 (0.00%)
After-Hours: 17:51
ClearPoint Neuro Debt to Equity Ratio : 3.375 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 3.375 |
| December 31, 2025 | 2.078 |
| September 30, 2025 | 2.252 |
| June 30, 2025 | 1.796 |
| March 31, 2025 | 0.172 |
| December 31, 2024 | 0.1405 |
| September 30, 2024 | 0.1274 |
| June 30, 2024 | 0.4294 |
| March 31, 2024 | 0.4019 |
| December 31, 2023 | 0.6584 |
| September 30, 2023 | 0.5816 |
| June 30, 2023 | 0.5206 |
| March 31, 2023 | 0.3641 |
| December 31, 2022 | 0.3249 |
| September 30, 2022 | 0.2997 |
| June 30, 2022 | 0.2818 |
| March 31, 2022 | 0.2663 |
| December 31, 2021 | 0.2518 |
| September 30, 2021 | 0.4572 |
| June 30, 2021 | 0.4205 |
| March 31, 2021 | 0.6201 |
| December 31, 2020 | 10.15 |
| September 30, 2020 | 121.12 |
| June 30, 2020 | 13.47 |
| March 31, 2020 | 6.212 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.5369 |
| September 30, 2019 | 0.3796 |
| June 30, 2019 | 0.3352 |
| March 31, 2019 | 9.311 |
| December 31, 2018 | 2.304 |
| September 30, 2018 | 1.335 |
| June 30, 2018 | 1.458 |
| March 31, 2018 | 1.064 |
| December 31, 2017 | 0.8438 |
| September 30, 2017 | 0.6584 |
| June 30, 2017 | 0.5503 |
| March 31, 2017 | -2.083 |
| December 31, 2016 | -5.941 |
| September 30, 2016 | 7.641 |
| June 30, 2016 | -1.527 |
| March 31, 2016 | -2.241 |
| December 31, 2015 | -4.095 |
| September 30, 2015 | -1.373 |
| June 30, 2015 | -1.342 |
| March 31, 2015 | -2.146 |
| December 31, 2014 | -76.68 |
| September 30, 2014 | -0.9594 |
| June 30, 2014 | -1.669 |
| March 31, 2014 | -2.375 |
| December 31, 2013 | -1.232 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| CONMED Corp. | 0.8459 |
| Integra LifeSciences Holdings Corp. | 1.956 |
| UFP Technologies, Inc. | 0.3556 |
| CytoSorbents Corp. | 13.47 |
| Lucid Diagnostics, Inc. | 6.701 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 93.42M |
| Total Liabilities (Quarterly) | 74.58M |
| Shareholders Equity (Quarterly) | 18.84M |
| Current Ratio | 5.789 |
| Net Debt Paydown Yield | -4.40% |